Strengthening Antimalarial Quality Assurance System in Nigeria: A Comprehensive Strategy for Ensuring the Safety and Effectiveness of Medications
| dc.contributor.author | Onyinye Obasi, Esther | |
| dc.date.accessioned | 2024-07-02T14:51:39Z | |
| dc.date.available | 2024-07-02T14:51:39Z | |
| dc.date.issued | 2024-05 | |
| dc.description.abstract | Nigeria's public health is seriously threatened by the widespread use of substandard and counterfeit antimalarial medications, which compromise treatment effectiveness, increase the burden of disease, and compromise patient outcomes. This research uses a thorough and multidisciplinary strategy to strengthen Nigeria's antimalarial quality assurance system in response to this urgent challenge. This research analyses the underlying reasons for medication quality oversights, assesses current regulatory frameworks, and pinpoints important areas for intervention by utilizing regulatory analysis, stakeholder interaction, and empirical investigations. Deficient regulatory supervision, vulnerabilities in the pharmaceutical supply chain, and low awareness among consumers are the main causes of the spread of inferior antimalarial medications, according to the research. The study cultivates cooperative partnerships with regulatory bodies, healthcare providers, pharmaceutical manufacturers, and community stakeholders to improve oversight, compliance, and transparency in the pharmaceutical supply chain. The research produces practical insights and evidence-based suggestions for enhancing Nigeria's antimalarial quality assurance system using surveys, interviews, and data analysis. These ideas, which aim to reduce the dangers associated with poor medicine delivery and protect patient safety, include regulatory reforms, capacity-building programs, technology driven solutions, and community empowerment techniques. Furthermore, by highlighting the perspectives and experiences of those impacted by pharmaceutical quality lapses, the study emphasizes the significance of patient-centred approaches in developing efficient interventions and regulations. A future in which every person has access to safe, efficient, and high-quality antimalarial drugs can be achieved by stakeholders working together by placing a priority on patient safety and well-being. This would advance the larger objective of eradicating malaria and improving health outcomes for all in Nigeria. | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14136/156 | |
| dc.title | Strengthening Antimalarial Quality Assurance System in Nigeria: A Comprehensive Strategy for Ensuring the Safety and Effectiveness of Medications | |
| dc.type | Thesis |